Get started
EDWARDS LIFESCIENCESEDWARDS LIFESCIENCESEDWARDS LIFESCIENCES

EDWARDS LIFESCIENCES

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

1EW chart


Full chart

1EW upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪42.04 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
10.65
Basic EPS (TTM)
6.24 EUR
Net income (FY)
‪1.27 B‬ EUR
Revenue (FY)
‪5.44 B‬ EUR
Shares float
‪579.56 M‬
Beta (1Y)
1.00

Employees


Employees (FY)
‪19.8 K‬
Change (1Y)
‪+2.5 K‬ +14.45%
Revenue / Employee (1Y)
‪274.77 K‬ EUR
Net income / Employee (1Y)
‪64.17 K‬ EUR

About Edwards Lifesciences Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Bernard J. Zovighian
Website
edwards.com
Headquarters
Irvine
Founded
1958
FIGI
BBG01K3WLKY5
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1EW news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

1EW highest yielding bonds


US28176EAD0
EDWARDS LIFE. 18/28
Yield to maturity
5.24%
Maturity date
Jun 15, 2028

Explore more bonds 

Frequently Asked Questions


The current price of 1EW is 71.66 EUR — it hasn't changed in the past 24 hours. Watch EDWARDS LIFESCIENCES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange EDWARDS LIFESCIENCES stocks are traded under the ticker 1EW.
1EW stock has fallen by −0.46% compared to the previous week, the month change is a 2.07% rise, over the last year EDWARDS LIFESCIENCES has showed a 4.31% increase.
We've gathered analysts' opinions on EDWARDS LIFESCIENCES future price: according to them, 1EW price has a max estimate of 87.23 EUR and a min estimate of 65.91 EUR. Watch 1EW chart and read a more detailed EDWARDS LIFESCIENCES stock forecast: see what analysts think of EDWARDS LIFESCIENCES and suggest that you do with its stocks.
1EW reached its all-time high on Mar 28, 2024 with the price of 88.06 EUR, and its all-time low was 55.14 EUR and was reached on Aug 2, 2024. View more price dynamics on 1EW chart.
See other stocks reaching their highest and lowest prices.
1EW stock is 0.00% volatile and has beta coefficient of 1.00. Track EDWARDS LIFESCIENCES stock price on the chart and check out the list of the most volatile stocks — is EDWARDS LIFESCIENCES there?
Today EDWARDS LIFESCIENCES has the market capitalization of ‪42.04 B‬, it has increased by 2.57% over the last week.
Yes, you can track EDWARDS LIFESCIENCES financials in yearly and quarterly reports right on TradingView.
EDWARDS LIFESCIENCES is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1EW earnings for the last quarter are 0.60 EUR per share, whereas the estimation was 0.60 EUR resulting in a 0.81% surprise. The estimated earnings for the next quarter are 0.53 EUR per share. See more details about EDWARDS LIFESCIENCES earnings.
EDWARDS LIFESCIENCES revenue for the last quarter amounts to ‪1.22 B‬ EUR, despite the estimated figure of ‪1.39 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.31 B‬ EUR.
1EW net income for the last quarter is ‪2.76 B‬ EUR, while the quarter before that showed ‪341.98 M‬ EUR of net income which accounts for 706.49% change. Track more EDWARDS LIFESCIENCES financial stats to get the full picture.
No, 1EW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 12, 2025, the company has ‪19.80 K‬ employees. See our rating of the largest employees — is EDWARDS LIFESCIENCES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EDWARDS LIFESCIENCES EBITDA is ‪1.57 B‬ EUR, and current EBITDA margin is 30.22%. See more stats in EDWARDS LIFESCIENCES financial statements.
Like other stocks, 1EW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EDWARDS LIFESCIENCES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EDWARDS LIFESCIENCES technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EDWARDS LIFESCIENCES stock shows the buy signal. See more of EDWARDS LIFESCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.